PPAR-alpha agonists (Pfizer)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePPAR-alpha agonists (Pfizer)
Drug Alias NamePPAR-alpha agonists (Pfizer)peroxisome proliferator-activated receptor alpha agonists (Pfizer)CP-775146CP-865520CP-868388 +[6] 
ClassificationSmall molecules
Mechanisms of ActionPeroxisome proliferator-activated receptor α agonistsLipid metabolism modulators
TargetsPeroxisome proliferator-activated receptor α
Therapy Area/IndicationsLipid Metabolism DisordersDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsLipid Metabolism DisordersDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A